Here are five things to know:
1. Surgeons may now use ELEOS to treat patients with bone loss caused by cancer, trauma or surgical procedures.
2. The system is designed to offer a surgeon flexibility and modularity when performing these complex cases.
3. ELEOS represents a long-term, reconstructive choice for oncology patients.
4. Patrick Treacy, Onkos Surgical founder and CEO, commented they are expecting a full launch of ELEOS in the first quarter of 2017.
5. Founded in 2015, Onkos Surgical is a privately held surgical oncology company.
More articles on devices:
Dr. Hythem P. Shadid of Genesis Orthopedics creates video highlighting 3-D implants: 3 takeaways
FDA claims 12 US hospitals did not report patient deaths, injuries linked to medical devices in timely manner — 6 things to know
Zimmer Biomet Q3 net sales up 4%, but lowers growth projections — shares drop 13%: 6 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
